Assessing quality of life

January 28, 2009

Article

Assessing Quality of Life in Patients With Glaucoma Using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire

Assessing Quality of Life in Patients With Glaucoma Using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire from the January 2009 issue of the Journal of Glaucoma.

To read the full article, please click here.

Dynamic range of focus recovery in presbyopes after laser scleral microporation

October 4th 2023

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

October 2nd 2023

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022

Distorted corneas: How to regularise them with minimally invasive surgery

September 27th 2023

US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Dynamic range of focus recovery in presbyopes after laser scleral microporation

October 4th 2023

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

October 2nd 2023

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022

Distorted corneas: How to regularise them with minimally invasive surgery

September 27th 2023

US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Dynamic range of focus recovery in presbyopes after laser scleral microporation

October 4th 2023

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

October 2nd 2023

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022

Distorted corneas: How to regularise them with minimally invasive surgery

September 27th 2023

US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Related Content

A close-up of an older woman's eye next to a vision chart. Image credit: ©Syda Productions – stock.adobe.com

Dynamic range of focus recovery in presbyopes after laser scleral microporation

October 4th 2023

Article

Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023

Podcast

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

October 2nd 2023

Article

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022

Podcast

Figure 1. An aberrated cornea prevents precise biometry.

Distorted corneas: How to regularise them with minimally invasive surgery

September 27th 2023

Article

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations

A man puts drops in his eyes. Image credit: ©9nong – stock.adobe.com

US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Article

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777